全文获取类型
收费全文 | 585篇 |
免费 | 32篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 11篇 |
妇产科学 | 8篇 |
基础医学 | 64篇 |
口腔科学 | 2篇 |
临床医学 | 82篇 |
内科学 | 113篇 |
皮肤病学 | 3篇 |
神经病学 | 20篇 |
特种医学 | 96篇 |
外科学 | 140篇 |
综合类 | 13篇 |
预防医学 | 17篇 |
药学 | 32篇 |
肿瘤学 | 16篇 |
出版年
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 7篇 |
2018年 | 6篇 |
2017年 | 7篇 |
2016年 | 4篇 |
2015年 | 4篇 |
2014年 | 13篇 |
2013年 | 14篇 |
2012年 | 18篇 |
2011年 | 21篇 |
2010年 | 15篇 |
2009年 | 8篇 |
2008年 | 18篇 |
2007年 | 15篇 |
2006年 | 16篇 |
2005年 | 18篇 |
2004年 | 25篇 |
2003年 | 14篇 |
2002年 | 19篇 |
2001年 | 17篇 |
2000年 | 29篇 |
1999年 | 18篇 |
1998年 | 9篇 |
1997年 | 9篇 |
1996年 | 7篇 |
1995年 | 7篇 |
1994年 | 8篇 |
1992年 | 10篇 |
1991年 | 20篇 |
1990年 | 29篇 |
1989年 | 25篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 15篇 |
1984年 | 22篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1970年 | 2篇 |
1969年 | 3篇 |
1968年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有618条查询结果,搜索用时 15 毫秒
21.
Chow AK Thompson CS Hogan MJ Banner D Sabourin LA Hakim AM 《Brain research. Molecular brain research》2002,99(1):75-81
Cortical spreading depression (CSD) has been shown to have neuroprotective effects when administered in advance of cerebral ischemia. The mechanism by which CSD induces its neuroprotective effect however remains to be elucidated. Since MAP kinases have been shown to impart neuroprotection in ischemic preconditioning paradigms, we attempted to determine the role CSD may have in the activation of MAPK. We show that CSD is capable of increasing the phosphorylation of ERK in a MEK-dependent manner. This phosphorylation is, however, transient, as phosphorylated ERK levels return to control levels 45 min after 2 h of CSD elicitation. Immunohistochemical analysis reveals that the phosphorylated form of ERK is located ubiquitously in cells of the CSD-treated cortex while CSD-elicited MEK phosphorylation resides solely in the nuclei. These data suggest that CSD may act via the MAP kinase pathways to mediate preconditioning. 相似文献
22.
23.
24.
25.
26.
Refractory pulmonary aspergillosis treated with caspofungin after heart–lung transplantation 总被引:2,自引:0,他引:2
Martin?R.?CarbyEmail author Margaret?E.?Hodson Nicholas?R.?Banner 《Transplant international》2004,17(9):545-548
Invasive pulmonary aspergillosis (IPA) is a serious complication of lung transplantation. Pre-mortem diagnosis is difficult and is made according to defined criteria. Most patients with a post mortem diagnosis of IPA only reach the possible or probable levels of diagnostic certainty during life. Here, we report a case of probable IPA that was refractory to conventional treatment, including amphotericin, but which responded to therapy with caspofungin. A 23-year-old man underwent heart–lung transplantation for cystic fibrosis. Ten years after transplantation he developed IPA. His condition continued to deteriorate despite treatment with itraconazole, liposomal amphotericin and flucytosine together with treatment of a concomitant infection with Pseudomonas aeruginosa. Following treatment with caspofungin there was progressive and sustained clinical and radiological improvement. No adverse reaction occurred during treatment. Caspofungin should be considered as an alternative treatment for IPA in lung transplant recipients who fail to respond to other therapy. 相似文献
27.
Inflammation is a hallmark of inflammatory bowel disease (IBD), and elevation of cAMP levels can inhibit the pro-inflammatory and tissue-destructive properties of leukocytes. Phosphodiesterase 4 (PDE4) is the predominant enzyme that metabolizes cAMP in inflammatory cells, and the anti-inflammatory and immunomodulatory potential of PDE4 inhibitors in human leukocytes, endothelium and epithelium is well documented. Although PDE4 inhibitors have been investigated as treatments for several inflammatory diseases, this has focused mainly on asthma and chronic obstructive disease (COPD). Historically, their clinical utility has been limited by nausea and emesis. However, the PDE4 inhibitors cilomilast and roflumilast have recently shown efficacy in asthma and COPD, with a reduced propensity to cause nausea and emesis. In this review, we summarize for the first time the evidence that PDE4 inhibitors might have therapeutic benefit in IBD, and discuss mechanisms of action beyond the inhibition of inflammatory cells. 相似文献
28.
Incremental importance of peak-exercise plasma levels of endothelin-1 and natriuretic peptides in chronic heart failure 总被引:2,自引:0,他引:2
Yousufuddin M Henein MY Flather M Wang D Shamim W O'Sullivan C Kemp M Kazzam E Banner NR Amrani M Coats AJ 《Journal of cardiovascular pharmacology》2001,38(3):468-473
Chronic heart failure (CHF) studies investigating the clinical, hemodynamic, and therapeutic importance of endothelin-1 (ET-1), atrial natriuretic peptide (ANP), and brain natriuretic peptide (BNP) are largely based on resting plasma levels, which may vary with prior exertion and postprandial status. This study investigated the importance of peak-exercise plasma levels of ET-1, ANP, and BNP in the assessment of left ventricular (LV) systolic function. Thirty-six male-patients ages 58 +/- 10 (mean +/- SD ) with NYHA class I-IV CHF due to coronary artery disease or idiopathic dilated cardiomyopathy were enrolled. LV systolic function was assessed by echocardiography and radionuclide ventriculography. Resting and peak cardiopulmonary exercise venous blood sampling and treadmill exercise testing were performed in the fasting state. Resting plasma levels of ET-1, ANP, and BNP were elevated compared with reference laboratory normal values. Exercise induced significant (p < 0.0001) increase in plasma levels of ET-1, ANP, and BNP. On univariate analysis peak-exercise plasma levels of ET-1, ANP, and BNP were more closely related to echocardiographically determined LV end-diastolic diameter and end-systolic diameter than their resting values. Multiple step-wise regression models identified resting and peak-exercise plasma levels of ET-1 and ANP but only the resting BNP as independent predictors of LV dimensions and systolic function. Peak exercise plasma levels of ANP and ET-1 are potentially more reliable and important than their resting levels as markers of LV systolic dysfunction and LV dimensions in patients with heart failure. 相似文献
29.
Mutation screening of manganese superoxide dismutase in amyotrophic lateral sclerosis 总被引:2,自引:0,他引:2
Seventy-seven cases of ALS were screened for mutations in the manganese superoxide dismutase gene (SOD2). DNA was extracted from CNS tissue and screened using single stranded conformation polymorphism and heteroduplex analysis. No mutations were identified in the entire coding region of the SOD2 gene. The known polymorphism in the mitochondrial targeting sequence was identified. No association was found between this polymorphism and ALS. A further polymorphism was detected in the intronic sequence upstream of exon 4, though no association with ALS was demonstrated. We therefore conclude that mutations in SOD2 do not appear to cause ALS. 相似文献
30.